DIN 02517868 — ARAZLO 0.045 %
ARAZLO is a lotion of Tazarotene marketed by BAUSCH HEALTH, CANADA INC.. The full Tazarotene monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02517868
- Brand name
- ARAZLO
- Active ingredient
- Tazarotene
- Strength
- 0.045 %
- Dosage form
- LOTION
- Route
- TOPICAL
- Manufacturer
- BAUSCH HEALTH, CANADA INC.
- Health Canada status
- MARKETED
- Drug class
- Retinoid (topical acetylenic retinoid)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.